Covid-19

A new study found that gut flora is positively correlated with human pro-inflammatory factors, which may underlie the susceptibility to severe novel coronavirus pneumonia in healthy individuals.

An ebook on Alibaba's Global MediXchange to help governments and front line medical professionals set up and operate 'Fangcang Shelter Hospitals' has been recently launched.

Gilead Sciences said Wednesday preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a 5-day dosage of antiviral drug remdesivir improved and more than half were discharged from the hospital within two weeks.

Using machine learning, a team of Western computer scientists and biologists have identified an underlying genomic signature for 29 different Covid-19 DNA sequences.

Novel coronavirus pneumonia victims worldwide have reached 3.11 million, but there is no specific drug or vaccine for humans to deal with it.

Starting in the fall of 2016 and continuing into 2018, researchers at Columbia University in Manhattan began collecting nasal swabs from 191 children, teachers, and emergency workers, asking them to record when they sneezed or had sore throats. The point was to create a map of common respiratory viruses and their symptoms, and how long people who recovered stayed immune to each one.

Cutting off the pathway of transmission of the virus is one of the key preventions and control measures for novel coronavirus pneumonia. Droplet and contact transmission have been shown to be the main routes of transmission of the novel coronavirus (SARS-CoV-2), and little is known about its aerosol route of transmission.

April 27, China National Biotec Group Company (CNBG) announced that the new coronavirus inactivated vaccine developed by CNBG Beijing Bioproducts Research Institute was approved for clinical trials by the State Food and Drug Administration, and the clinical trial was officially launched in Henan on April 28.

The development and production of a vaccine have become a global race until a way is found to end the new coronavirus epidemic.

A vaccine for high-risk groups such as health care workers could be available as early as this year, faster than initially thought, according to a global group central to the development of a new coronavirus vaccine.